Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 36 Records) |
| Query Trace: Colorectal Neoplasms and XRCC3[original query] |
|---|
| Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. Journal of biomedical science 2007 Mar 14 (2): 183-93. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL |
| Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. The pharmacogenomics journal 2008 Aug 8 (4): 278-88. Ruzzo A, Graziano F, Loupakis F, Santini D, Catalano V, Bisonni R, Ficarelli R, Fontana A, Andreoni F, Falcone A, Canestrari E, Tonini G, Mari D, Lippe P, Pizzagalli F, Schiavon G, Alessandroni P, Giustini L, Maltese P, Testa E, Menichetti E T, Magnani |
| Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. European journal of cancer (Oxford, England : 1990) 2008 Jun 44 (9): 1229-37. Martinez-Balibrea Eva, Abad Albert, Aranda Enrique, Sastre Javier, Manzano Jose Luis, Díaz-Rubio Eduardo, Gómez-España Auxiliadora, Aparicio Jorge, García Teresa, Maestu Inmaculada, Martínez-Cardús Anna, Ginés Alba, Guino Elisabet, |
| Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer research 0 28 (5B): 2941-6. Improta Giuseppina, Sgambato Alessandro, Bianchino Gabriella, Zupa Angela, Grieco Vitina, La Torre Giuseppe, Traficante Antonio, Cittadini Achil |
| A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. International journal of colorectal disease 2010 Feb 25 (2): 169-80. Jiang Zheng, Li Chunxiang, Xu Ye, Cai Sanj |
| Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. Journal of cancer research and clinical oncology 2010 Oct 136 (10): 1517-25. Wang Jingwen, Zhao Yang, Jiang Jing, Gajalakshmi Vendhan, Kuriki Kiyonori, Nakamura Seiichi, Akasaka Susumu, Ishikawa Hideki, Suzuki Sadao, Nagaya Teruo, Tokudome Shink |
| Polymorphisms in RAD51, XRCC2 and XRCC3 genes of the homologous recombination repair in colorectal cancer--a case control study. Molecular biology reports 2011 Apr 38 (4): 2849-54. Krupa Renata, Sliwinski Tomasz, Wisniewska-Jarosinska Maria, Chojnacki Jan, Wasylecka Maja, Dziki Lukasz, Morawiec Jan, Blasiak Janu |
| Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population. Current medical research and opinion 2011 Jul 27 (7): 1295-302. Canbay Emel, Cakmakoglu Bedia, Zeybek Umit, Sozen Seyma, Cacina Canan, Gulluoglu Mine, Balik Emre, Bulut Turker, Yamaner Sumer, Bugra Durs |
| The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer. Molecular biology reports 2012 Jan 39 (1): 527-34. Gil Justyna, Ramsey Dave, Stembalska Agnieszka, Karpinski Pawel, Pesz Karolina A, Laczmanska Izabela, Leszczynski Przemyslaw, Grzebieniak Zygmunt, Sasiadek Maria Malgorza |
| DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome. Cancer epidemiology 2012 Apr 36 (2): 183-9. Reeves Stuart G, Meldrum Cliff, Groombridge Claire, Spigelman Allan, Suchy Janina, Kurzawski Grzegorz, Lubinski Jan, Scott Rodney |
| A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. The pharmacogenomics journal 2013 Oct 13 (5): 403-9. Cecchin E, D'Andrea M, Lonardi S, Zanusso C, Pella N, Errante D, De Mattia E, Polesel J, Innocenti F, Toffoli |
| Prediction of genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 in the survival of colorectal cancer receiving chemotherapy in the Chinese population. Hepato-gastroenterology 2012 Jun 59 (116): 977-80. Liu Yang, Chen Haihui, Chen Limin, Hu Chunho |
| Genetic polymorphisms of DNA repair genes XRCC1 and XRCC3 and risk of colorectal cancer in Chinese population. Asian Pacific journal of cancer prevention : APJCP 2012 13 (2): 665-9. Zhao Yi, Deng Xin, Wang Zhen, Wang Qiang, Liu Yix |
| Association between XRCC1 and XRCC3 polymorphisms and colorectal cancer risk: a meta-analysis of 23 case-control studies. Molecular biology reports 2012 Dec . Liu L, Miao L, Ji G, Qiang F, Liu Z, Fan Z |
| Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies. Gene 2013 Jul 523 (1): 10-9. He Xiao-Feng, Wei Wu, Li Jia-Lin, Shen Xu-Liang, Ding Da-peng, Wang Su-Lan, Liu Zhi-Zhong, Qin Jiang-Bo, Wu Li-Xia, Xie Dao-L |
| Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Jun 34 (3): 1421-9. Wang ZhiZhen, Zhang Wenche |
| Association of Thr241Met polymorphism of XRCC3 gene with risk of colorectal cancer in the Polish population. Polish journal of pathology : official journal of the Polish Society of Pathologists 2013 Oct 64 (3): 185-90. Mucha Bartosz, Przybylowska-Sygut Karolina, Dziki Adam Janusz, Dziki Lukasz, Sygut Andrzej, Majsterek Ireneu |
| CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients. Medical oncology (Northwood, London, England) 2014 Jul 31 (7): 72. Gil Justyna, Gaj Pawe?, Misiak B?a?ej, Ostrowski Jerzy, Karpinski Pawel, Jarczy?ska Alicja, Kielan Wojciech, Sasiadek Maria Malgorza |
| No association between XRCC3 Thr241Met and XPD Lys751Gln polymorphisms and the risk of colorectal cancer in West Algerian population: a case-control study. Medical oncology (Northwood, London, England) 2014 May 31 (5): 942. Moghtit Fatima Zohra, Aberkane Meriem Samia, Le Morvan Valérie, Louhibi Lotfi, Bellot Ricardo, Bousahba Abdelkader, Megaiz Ahlem, Fodil Mostefa, Mediene-Benchekor Sounnia, Zemani-Fodil Faouzia, Boudjema Abdallah, Robert Jacques, Saidi-Mehtar Nadhi |
| Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
| AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. The pharmacogenomics journal 2015 Aug . Kjersem J B, Thomsen M, Guren T, Hamfjord J, Carlsson G, Gustavsson B, Ikdahl T, Indrebø G, Pfeiffer P, Lingjærde O, Tveit K M, Wettergren Y, Kure E |
| Association between the XRCC3 Thr241Met polymorphism and risk of colorectal cancer: a meta analysis of 5,193 cases and 6,645 controls. Asian Pacific journal of cancer prevention : APJCP 2015 16 (6): 2263-8. Namazi Abolfazl, Abedinzadeh Maryam, Nourbaksh Parisa, Neamatzadeh Hosse |
| Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
| Meta-analysis of the relationship between XRCC3 T241M polymorphism and colorectal cancer susceptibility. Genetics and molecular research : GMR 2015 14 (4): 14831-9. Zhang L Z, Li Y S, Liu H |
| Comment on: “Association Between the XRCC3 Thr241Met Polymorphism and Risk of Colorectal Cancer: A Meta-Analysis of 5,193 Cases and 6,645 Controls”. Asian Pacific journal of cancer prevention : APJCP 2016 12 17 (11): 4803-4804. Sahami-Fard Mohammad Hossein, Farashahi Yazd Ehs |
| Genetic variants of DNA repair-related genes predict efficacy of TAS-102 in patients with refractory metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 1015-1022. Suenaga M, Schirripa M, Cao S, Zhang W, Yang D, Murgioni S, Rossini D, Marmorino F, Mennitto A, Ning Y, Okazaki S, Berger M D, Miyamoto Y, Gopez R, Barzi A, Yamaguchi T, Loupakis F, Lenz H |
| Colorectal Cancer Carcinogenesis: a Multivariate Genetic Model in a Cohort of Romanian Population. Clinical laboratory 2017 Apr 63 (4): 647-658. Procopciuc Lucia M, Osian Gelu, Iancu Mihae |
| XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer. PloS one 2018 13 (2): e0192316. He Yanjing, Penney Michelle E, Negandhi Amit A, Parfrey Patrick S, Savas Sevtap, Yilmaz Yildiz |
| Polymorphisms of XRCC3 and XRCC7 and Colorectal Cancer Risk in Khorasan Razavi Province, Iran. Asian Pacific journal of cancer prevention : APJCP 2019 07 20 (7): 2153-2158. Mehrzad Jamshid, Dayyani Mahdieh, Khorasani Mohammadreza Erfani |
| Single Nucleotide Variants Associated with Colorectal Cancer Among Iranian Patients: A Narrative Review. Pharmacogenomics and personalized medicine 2020 6 13 167-180. Jamshidi Mohammad, Mohammadi Pour Somayeh, Mahmoudian-Sani Mohammad-Re |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 18, 2023
- Content source: